PortfoliosLab logoPortfoliosLab logo
XBIT vs. XBI
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

XBIT vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in XBiotech Inc. (XBIT) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

XBIT vs. XBI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
XBIT
XBiotech Inc.
-2.09%-39.49%-1.25%13.96%-68.46%-17.46%-16.15%267.42%28.93%-61.07%
XBI
SPDR S&P Biotech ETF
5.43%35.89%1.01%7.60%-25.87%-20.45%48.33%32.56%-15.28%43.77%

Returns By Period

In the year-to-date period, XBIT achieves a -2.09% return, which is significantly lower than XBI's 5.43% return. Over the past 10 years, XBIT has underperformed XBI with an annualized return of -11.73%, while XBI has yielded a comparatively higher 9.39% annualized return.


XBIT

1D
-0.43%
1M
0.86%
YTD
-2.09%
6M
-11.36%
1Y
-22.52%
3Y*
-12.14%
5Y*
-30.80%
10Y*
-11.73%

XBI

1D
0.64%
1M
1.58%
YTD
5.43%
6M
27.21%
1Y
65.07%
3Y*
19.25%
5Y*
-1.16%
10Y*
9.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XBIT vs. XBI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XBIT
XBIT Risk / Return Rank: 2121
Overall Rank
XBIT Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
XBIT Sortino Ratio Rank: 2424
Sortino Ratio Rank
XBIT Omega Ratio Rank: 2424
Omega Ratio Rank
XBIT Calmar Ratio Rank: 1616
Calmar Ratio Rank
XBIT Martin Ratio Rank: 1919
Martin Ratio Rank

XBI
XBI Risk / Return Rank: 9393
Overall Rank
XBI Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
XBI Sortino Ratio Rank: 9494
Sortino Ratio Rank
XBI Omega Ratio Rank: 8989
Omega Ratio Rank
XBI Calmar Ratio Rank: 9696
Calmar Ratio Rank
XBI Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XBIT vs. XBI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for XBiotech Inc. (XBIT) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


XBITXBIDifference

Sharpe ratio

Return per unit of total volatility

-0.38

2.28

-2.66

Sortino ratio

Return per unit of downside risk

-0.22

2.99

-3.21

Omega ratio

Gain probability vs. loss probability

0.98

1.38

-0.40

Calmar ratio

Return relative to maximum drawdown

-0.70

4.41

-5.12

Martin ratio

Return relative to average drawdown

-1.17

16.21

-17.37

XBIT vs. XBI - Sharpe Ratio Comparison

The current XBIT Sharpe Ratio is -0.38, which is lower than the XBI Sharpe Ratio of 2.28. The chart below compares the historical Sharpe Ratios of XBIT and XBI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


XBITXBIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.38

2.28

-2.66

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.48

-0.04

-0.45

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.15

0.29

-0.45

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.23

0.36

-0.59

Correlation

The correlation between XBIT and XBI is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

XBIT vs. XBI - Dividend Comparison

XBIT has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.34%.


TTM20252024202320222021202020192018201720162015
XBIT
XBiotech Inc.
0.00%0.00%0.00%0.00%0.00%22.46%0.00%0.00%0.00%0.00%0.00%0.00%
XBI
SPDR S&P Biotech ETF
0.34%0.37%0.15%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%

Drawdowns

XBIT vs. XBI - Drawdown Comparison

The maximum XBIT drawdown since its inception was -92.67%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for XBIT and XBI.


Loading graphics...

Drawdown Indicators


XBITXBIDifference

Max Drawdown

Largest peak-to-trough decline

-92.67%

-63.89%

-28.78%

Max Drawdown (1Y)

Largest decline over 1 year

-39.43%

-13.39%

-26.04%

Max Drawdown (5Y)

Largest decline over 5 years

-87.21%

-55.04%

-32.17%

Max Drawdown (10Y)

Largest decline over 10 years

-90.72%

-63.89%

-26.83%

Current Drawdown

Current decline from peak

-91.38%

-25.70%

-65.68%

Average Drawdown

Average peak-to-trough decline

-69.78%

-20.91%

-48.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

23.84%

3.65%

+20.19%

Volatility

XBIT vs. XBI - Volatility Comparison

The current volatility for XBiotech Inc. (XBIT) is 7.77%, while SPDR S&P Biotech ETF (XBI) has a volatility of 11.31%. This indicates that XBIT experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


XBITXBIDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.77%

11.31%

-3.54%

Volatility (6M)

Calculated over the trailing 6-month period

40.36%

19.25%

+21.11%

Volatility (1Y)

Calculated over the trailing 1-year period

59.87%

28.95%

+30.92%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

64.08%

32.23%

+31.85%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.92%

32.15%

+43.77%